Therefore, antihypertensive treatment is the most important hipertenzija to stroke risk reduction. International and national guidelines recommend antihypertensive treatment for both primary and secondary prevention. All stroke patients and patients with transient ischaemic attack TIA should be considered as high-risk patients. Hypertension increases the risk of recurrent strokes.
There are limited data directly addressing the role of hypertension treatment in individuals with stroke or TIA. No consensus exists as to when the antihypertensive treatment should be started in the initial phase. Experimental and clinical data suggest that reducing the activity of the renin-angiotensin aldosterone system RAAS may have beneficial effects hipertenzija lowering the blood pressure.
There is increasing evidence of cerebroprotective effects of RAAS-modifying agents, such as angiotensin receptor antagonists or angiotensin hipertenzija enzyme ACE inhibitors. Currently, the most important goal in primary and secondary prevention of stroke is a strict blood pressure control.
Antihypertensive treatment is recommended for prevention of both recurrent stroke and other vascular events in individuals with hipertenzija history of ischaemic stroke or TIA. Key words:.